Neuromodulatory Effects of Substantia Nigra Pars Reticulata Deep Brain Stimulation (SNr-DBS) in the 6-Hydroxydopamine Rat Model of Parkinson's Disease. [PDF]
Medicina (Kaunas)Turgut E +9 more
europepmc +1 more source
Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson's disease. [PDF]
Neural Regen Res, 2023 Zhang HY +7 more
europepmc +1 more source
Mode of Action of Toxin 6-Hydroxydopamine in SH-SY5Y Using NMR Metabolomics. [PDF]
MoleculesTamuli R +3 more
europepmc +1 more source
Quantifying changes in local basal ganglia structural connectivity in the 6-hydroxydopamine model of Parkinson's Disease using correlational tractography. [PDF]
Int IEEE EMBS Conf Neural Eng, 2023 Moshchin M +11 more
europepmc +1 more source
Mitochondrial DNA Damage in Substantia Nigra Pars Compacta Astrocytes Exacerbates Dopaminergic Neuron Loss in a 6-Hydroxydopamine Mouse Model of Parkinsonism. [PDF]
Cell Mol NeurobiolAyala DA +9 more
europepmc +1 more source
Optogenetic Globus Pallidus Stimulation Improves Motor Deficits in 6-Hydroxydopamine-Lesioned Mouse Model of Parkinson's Disease. [PDF]
Int J Mol Sci, 2023 Di Bisceglie Caballero S +5 more
europepmc +1 more source
Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease. [PDF]
Int Neurourol J, 2022 Kim B +10 more
europepmc +1 more source
Pathogenic mechanism underlying parkinsonism induced by neurotoxicants (MPTP and 6-hydroxydopamine) and α-synuclein: a unifying hypothesis. [PDF]
J Mol Cell BiolZhu BT.
europepmc +1 more source
Ethyl pyruvate protects SHSY5Y cells against 6-hydroxydopamine-induced neurotoxicity by upregulating autophagy. [PDF]
PLoS One, 2023 Luo Y, Sakamoto K.
europepmc +1 more source